CF
NAUT icon

Corebridge Financial’s Nautilus Biotechnolgy NAUT Stock Holding History

Corebridge Financial’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,868
Closed -$20.6K – 1758
2025
Q1 		$20.6K Sell
23,868
-354
-1% -$526 ﹤0.01% 2903
2024
Q4 		$40.7K Sell
24,222
-1,828
-7% -$4.37K ﹤0.01% 2875
2024
Q3 		$74.2K Sell
26,050
-161
-0.6% -$417 ﹤0.01% 2745
2024
Q2 		$61.3K Buy
+26,211
New +$68.4K ﹤0.01% 2833

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Corebridge Financial's NAUT Position: Q2 2025 in Review

Corebridge Financial sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 23,868 shares — an estimated $20.6K sold.

Corebridge Financial first reported a position in NAUT in Q2 2024 and held it in 4 quarters. The position peaked at $74.2K in Q3 2024. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • Corebridge Financial reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 23,868 Nautilus Biotechnolgy shares in Q2 2025, an estimated $20.6K.
  • Corebridge Financial first reported a position in Nautilus Biotechnolgy in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Nautilus Biotechnolgy position peaked at $74.2K in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.